Bruker (BRKR) Financial Analysis & Valuation | Quarter Chart
Bruker (BRKR)
BRKRPrice: $59.71
Fair Value: 🔒
🔒score
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Superc... more
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical an... more
Description
Shares
| Market Cap | $9.09B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Frank H. Laukien |
| IPO Date | 2000-08-04 | CAGR | 0.18% |
| Employees | 11,396 | Website | www.bruker.com |
| Div. Yield | 0.27% | Payout Ratio | -3.78% |
| Buy Back Yield | — | Total Yield | 0.27% |
BRKR chart loading...
Fundamentals
Technicals
| Enterprise Value | $9.02B | P/E Ratio | 32.81 |
| Forward P/E | 24.51 | PEG Ratio | — |
| P/S Ratio | 3.35 | P/B Ratio | 4.75 |
| P/CF Ratio | 82.9 | P/FCF Ratio | 226.73 |
| EPS | $1.82 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 0.36% | Gross Margin | 0.46% |
| Operating Margin | 0.06% | Profit Margin | -0% |
| ROE | -0.01% | ROA | — |
| ROCE | 0.04% | Current Ratio | 1.55 |
| Quick Ratio | 0.72 | Cash Ratio | 0.1 |
| Debt/Equity | 0.68 | Interest Coverage | 3.43 |
| Altman Z Score | 2.78 | Piotroski Score | 3 |